These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2426936)

  • 21. [Pindolol in myocardial infarction patients: (author's transl)].
    Samek L; Stürzenhofecker P; Roskamm H
    MMW Munch Med Wochenschr; 1980 Jul; 122(29):1071-4. PubMed ID: 6157984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large arteries in hypertension: heterogeneous haemodynamic response to beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity.
    Simon AC; Levenson J; Pithois-Merli I
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):45S-49S. PubMed ID: 2894224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The sympathomimetic activity of (+/-)-pindolol at beta 1- and beta 2-adrenoceptor sites.
    Mian MA; Malta E
    Eur J Pharmacol; 1985 Feb; 109(1):65-71. PubMed ID: 2986991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-adrenergic-mediated Cl secretion: evidence for additional non-cAMP-dependent pathway of effect.
    Feldman RD; Brotherton A; Welsh MJ
    Am J Physiol; 1990 Dec; 259(6 Pt 1):L426-31. PubMed ID: 2175556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.
    Hedberg A; Gerber JG; Nies AS; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Oct; 239(1):117-23. PubMed ID: 3020227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity on local wall motion abnormalities in patients with coronary heart disease.
    Gleichmann U; Fassbender D; Trieb G; Mannebach H; Ohlmeier H
    Br J Clin Pharmacol; 1982; 13(Suppl 2):301S-304S. PubMed ID: 6125180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adrenergic beta receptor blockaders with intrinsic sympathomimetic activity in the treatment of arterial hypertension].
    Pyda M; Grajek S
    Kardiol Pol; 1988; 31(4):261-70. PubMed ID: 2906104
    [No Abstract]   [Full Text] [Related]  

  • 29. Pindolol--a new beta-adrenergic blocking agent with intrinsic sympathomimetic activity in the management of mild and moderate hypertension.
    Schirger A; Sheps SG; Spiekerman RE; Harman TR; Kleven MK
    Mayo Clin Proc; 1983 May; 58(5):315-8. PubMed ID: 6843182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pindolol in the treatment of arrhythmias caused by exertion].
    Giordano A; Tamiz A; Schiavo B; Rossi P
    Minerva Med; 1979 Nov; 70(51):3499-501. PubMed ID: 42861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of pindolol in neurocardiogenic syncope.
    Iskos D; Dutton J; Scheinman MM; Lurie KG
    Am J Cardiol; 1998 Nov; 82(9):1121-4, A9. PubMed ID: 9817494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sympathomimetic effects of pindolol in depression.
    Chaouloff F
    Trends Pharmacol Sci; 2001 Nov; 22(11):554-5. PubMed ID: 11698094
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of beta-adrenoceptor blockade on left ventricular function.
    Hahn B; Strauer BE
    Br J Clin Pharmacol; 1982; 13(Suppl 2):305S-307S. PubMed ID: 6125181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations].
    Bubiński R
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on circadian heart rate.
    Fitscha P; Tiso B; Meisner W; Spitzer D
    Br J Clin Pharmacol; 1982; 13(Suppl 2):211S-215S. PubMed ID: 6125172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pindolol therapy for bradycardia/tachycardia syndrome.
    Schamp DJ; Carliner NH; Peters RW
    Can J Cardiol; 1987; 3(5):212-4. PubMed ID: 3607587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.
    Ades PA
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):29S-33S. PubMed ID: 2894223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise.
    Hombach V; Braun V; Höpp HW; Gil-Sanchez D; Behrenbeck DW; Tauchert M; Hilger HH
    Br J Clin Pharmacol; 1982; 13(Suppl 2):285S-293S. PubMed ID: 6125178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension.
    v d Meiracker A; Man in't Veld AJ; van Eck HR; Wenting GJ; Schalekamp MA
    J Hypertens Suppl; 1984 Dec; 2(3):S581-3. PubMed ID: 6100755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.